Hany Tawfeek, Mahmoud K. Nour, Akram A. Bary, Alia A. Fattah
{"title":"Contemporary retrospective analysis of acute coronary syndrome. An Egyptian study","authors":"Hany Tawfeek, Mahmoud K. Nour, Akram A. Bary, Alia A. Fattah","doi":"10.1016/j.ejccm.2016.05.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Cardiovascular disease is the leading cause of death in Egypt and worldwide, placing great strain on the world’s health systems. This is one of the few Egyptian registries dealing with patients with acute coronary syndrome admitted in critical care department, Cairo University.</p></div><div><h3>Methods</h3><p>This is a retrospective non-controlled cohort study of patients with acute coronary syndrome admitted from January 2010 to December 2012. Retrospective analysis of these patients data were retrieved through reviewing written paper and electronic database.</p></div><div><h3>Results</h3><p>A total number of 503 patients were enrolled in our study. The mean age was 57.2<!--> <!-->±<!--> <!-->10.4<!--> <!-->years. Their pain duration was 14<!--> <!-->±<!--> <!-->24.4<!--> <!-->h. Average length of stay was (7<!--> <!-->±<!--> <!-->4.4<!--> <!-->days). Primary percutaneous coronary intervention (PCI) was done to 154 patients (30.6%), while we had 105 elective PCI procedures (20.9%). Major adverse cardiac events (MACE) were higher in patients with higher age (60<!--> <!-->years vs 56.7<!--> <!-->years <em>P</em> value 0.021), STEMI (25.7% vs. 18% in UA/NSTEMI <em>P</em> value 0.002), higher CKMB levels (157iu/l vs 89iu/l <em>P</em> value0.019), and higher Killip class upon presentation (class III-IV 64.9% vs 2.2% class I-II <em>p</em> <!--><<!--> <!-->0.001). Patients with UA/NSTEMI who were treated conservatively developed statistically significant higher incidence of MACE as compared to those treated interventionally (23.4% vs. 13.5% <em>P</em> value 0.031). Patients with STEMI who were treated without intervention have significant higher incidence of MACE than those who were treated interventionally (15.4% vs. 5.5% <em>p</em> <em>=</em> <!-->0.46).</p></div><div><h3>Conclusion</h3><p>1. Higher incidence of MACE was observed in the higher age group, higher levels of cardiac biomarkers, and higher Killip class. 2. Outcome was affected by early interventional treatment in all patient groups.</p></div>","PeriodicalId":31233,"journal":{"name":"Egyptian Journal of Critical Care Medicine","volume":"4 2","pages":"Pages 79-84"},"PeriodicalIF":0.3000,"publicationDate":"2016-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ejccm.2016.05.001","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Egyptian Journal of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2090730316300238","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CRITICAL CARE MEDICINE","Score":null,"Total":0}
引用次数: 4
Abstract
Background
Cardiovascular disease is the leading cause of death in Egypt and worldwide, placing great strain on the world’s health systems. This is one of the few Egyptian registries dealing with patients with acute coronary syndrome admitted in critical care department, Cairo University.
Methods
This is a retrospective non-controlled cohort study of patients with acute coronary syndrome admitted from January 2010 to December 2012. Retrospective analysis of these patients data were retrieved through reviewing written paper and electronic database.
Results
A total number of 503 patients were enrolled in our study. The mean age was 57.2 ± 10.4 years. Their pain duration was 14 ± 24.4 h. Average length of stay was (7 ± 4.4 days). Primary percutaneous coronary intervention (PCI) was done to 154 patients (30.6%), while we had 105 elective PCI procedures (20.9%). Major adverse cardiac events (MACE) were higher in patients with higher age (60 years vs 56.7 years P value 0.021), STEMI (25.7% vs. 18% in UA/NSTEMI P value 0.002), higher CKMB levels (157iu/l vs 89iu/l P value0.019), and higher Killip class upon presentation (class III-IV 64.9% vs 2.2% class I-II p < 0.001). Patients with UA/NSTEMI who were treated conservatively developed statistically significant higher incidence of MACE as compared to those treated interventionally (23.4% vs. 13.5% P value 0.031). Patients with STEMI who were treated without intervention have significant higher incidence of MACE than those who were treated interventionally (15.4% vs. 5.5% p= 0.46).
Conclusion
1. Higher incidence of MACE was observed in the higher age group, higher levels of cardiac biomarkers, and higher Killip class. 2. Outcome was affected by early interventional treatment in all patient groups.
背景心血管疾病是埃及和全世界的主要死亡原因,给世界卫生系统带来了巨大压力。这是埃及为数不多的登记中心之一,处理在开罗大学重症监护室收治的急性冠状动脉综合征患者。方法对2010年1月至2012年12月收治的急性冠状动脉综合征患者进行回顾性非对照队列研究。回顾性分析这些患者的资料通过查阅书面论文和电子数据库进行检索。结果共纳入503例患者。平均年龄57.2±10.4岁。疼痛持续时间(14±24.4 h),平均住院时间(7±4.4 d)。初步经皮冠状动脉介入治疗(PCI) 154例(30.6%),而我们有105例选择性PCI手术(20.9%)。年龄越大(60岁vs 56.7岁P值0.021)、STEMI (25.7% vs 18% UA/NSTEMI P值0.002)、CKMB水平越高(157iu/l vs 89iu/l P值0.019)、就诊时Killip等级越高(III-IV级64.9% vs 2.2% I-II级P <0.001)。保守治疗的UA/NSTEMI患者MACE发生率高于介入治疗的患者(23.4%比13.5%,P值为0.031)。STEMI患者不进行干预治疗的MACE发生率显著高于介入治疗组(15.4% vs 5.5% p = 0.46)。年龄越大,心脏生物标志物水平越高,Killip分级越高,MACE的发生率越高。2. 所有患者组的预后均受早期介入治疗的影响。
期刊介绍:
The Egyptian Journal of Critical Care Medicine is the official Journal of the Egyptian College of Critical Care Physicians, the most authoritative organization of Egyptian physicians involved in the multi-professional field of critical care medicine. The journal is intended to provide a peer-reviewed source for multidisciplinary coverage of general acute and intensive care medicine and its various subcategories including cardiac, pulmonary, neuro, renal as well as post-operative care. The journal is proud to have an international multi-professional editorial board in the broad field of critical care that will assist in publishing promising research and breakthrough reports that lead to better patients care in life threatening conditions, and bring the reader a quick access to the latest diagnostic and therapeutic approaches in monitoring and management of critically ill patients.